- What is breast reconstruction?
- New choices in breast cancer surgery and reconstruction
- Types of breast reconstruction
- Nipple and areola reconstruction
- Choosing your plastic surgeon for breast reconstruction
- Before breast reconstruction surgery
- After breast reconstruction surgery
- Can breast reconstruction hide cancer, or make it come back?
- Our Reach To Recovery program
- To learn more
American Cancer Society. Cancer Facts and Figures 2014. Atlanta, Ga. Accessed at www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2014 on December 4, 2014.
American Society of Plastic Surgeons. Breast Reconstruction. Accessed at www.plasticsurgery.org/reconstructive-procedures/breast-reconstruction.html on December 4, 2014.
Ananthakrishnan P, Lucas A. Options and considerations in the timing of breast reconstruction after mastectomy. Cleve Clin J Med. 2008;75 Suppl 1:S30-33.
Andrades P, Fix RJ, Danilla S, Howell RE 3rd, et al. Ischemic complications in pedicle, free, and muscle sparing transverse rectus abdominis myocutaneous flaps for breast reconstruction. Ann Plast Surg. 2008;60(5):562-567.
Bishara MR, Ross C, Sur M . Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009;4:11.
Boehmler JH 4th, Butler CE, Ensor J, Kronowitz SJ. Outcomes of various techniques of abdominal fascia closure after TRAM flap breast reconstruction. Plast Reconstr Surg. 2009;123(3):773-781.
Breastreconstruction.org. Accessed at: www.breastreconstruction.org/index.htm on December 4, 2014.
Burstein HJ, Harris JR, Morrow M. Malignant Tumors of the Breast. In DeVita VT, Hellman S, Lawrence TS, Rosenberg SA (eds) Cancer Principles and Practice of Oncology, 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008.
Chai SM, Kavangh S, Ooi SS, et al. Anaplastic large-cell lymphoma associated with breast implants: a unique entity within the spectrum of peri-implant effusions. Diagn Cytopathol. 2014;42(11):929-938.
Crowe JP, Kim JA, Yetman R, Banbury J, et al. Nipple-Sparing Mastectomy: Technique and Results of 54 Procedures. Arch Surg. 2004;139:148-150.
Djohan R, Gage E, Bernard S. Breast reconstruction options following mastectomy. Cleve Clin J Med. 2008;75 Suppl 1:S17-23.
Farhadi J, Maksvytyte GK, Schaefer DJ, Pierer G, Scheufler O. Reconstruction of the nipple-areola complex: an update. J Plastic, Reconstructive & Aesthetic Surgery. 2006;59:40-53.
Gerber B, Krause A, Dieterich M, Kundt G, Reimer T. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009;249(3):461-468.
Guerra AB, Metzinger SE, Bidros RS, et al. Breast reconstruction with gluteal artery perforator (GAP) flaps. Annals of Plastic Surgery. 2004;52(2):118-125.
Hedén P, Bronz G, Elberg JJ, et al. Long-term safety and effectiveness of style 410 highly cohesive silicone breast implants. Aesthetic Plast Surg. 2009;33(3):430-436.
Kaufman GJ, Sakr RA, Inguenault C, et al. Silicone migration to the contralateral axillary lymph nodes and breast after highly cohesive silicone gel implant failure: a case report. Cases J. 2009;2:6420. doi: 10.1186/1757-1626-0002-0000006420.
Kim SM, Park JM. Mammographic and ultrasonographic features after autogenous myocutaneous flap reconstruction mammoplasty. J Ultrasound in Medicine. 2004;23(2):275-282.
Kufe, DW, Pollack, RE, Weichselbaum, RR, Bast, RC, Gansler, TS, Holland, JF, Frei, E. Cancer Medicine, 6th ed. Hamilton, Ontario: B.C. Decker; 2003.
Li S, Lee AK. Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol. 2009;3(1):117-127.
Namnoum JD. Expander/implant reconstruction with AlloDerm: recent experience. Plast Reconstr Surg. 2009;124(2):387-394.
Newman MI, Swartz KA, Samson MC, et al. The true incidence of near-term postoperative complications in prosthetic breast reconstruction utilizing human acellular dermal matrices: a meta-analysis. Aesthetic Plast Surg. 2011;35(1):100-106.
Nguyen MD, Chen C, Colakoğlu S, et al. Infectious Complications Leading to Explantation in Implant-Based Breast Reconstruction With AlloDerm. Eplasty. 2010;10:e48.
Petit JY, Veronesi U, Orecchia R, et al. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Breast Cancer Res Treat. 2006;96(1):47-51.
Petit JY, Veronesi U, Rey P, et al. Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases. Breast Cancer Res Treat. 2008 Mar 22.
Resnick B, Belcher AE. Breast Reconstruction. American Journal Nursing. 2002;102:26-33.
Spear SL, Parikh PM, Reisin E, Menon NG. Acellular dermis-assisted breast reconstruction. Aesthetic Plast Surg. 2008;32(3):418-425.
Taylor CW, Horgan K, Dodwell D. Oncological aspects of breast reconstruction. The Breast. 2005;14:118-130.
US Food and Drug Administration. Breast Implant Surgery. Updated January 28, 2014. Accessed at www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm064176.htm on December 4, 2014.
US Food and Drug Administration. FDA approves new silicone gel-filled breast implant (News Release, Feb 20, 2013). Accessed at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340447.htm?source=govdelivery on December 4, 2014.
US Food and Drug Administration. FDA Update on the Safety of Silicone Gel-Filled breast Implants. Updated June 2011. Accessed at www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/UCM260090.pdf on December 4, 2014.
US Food and Drug Administration. Guidance for Industry and FDA Staff -- Saline, Silicone Gel, and Alternative Breast Implants. November 2006. Accessed at www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071228.htm#85 on December 4, 2014.
US Food and Drug Administration. Medical Device Safety Communication: Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants, January 26, 2011. Accessed at www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm240000.htm on December 4, 2014.
Weathers WM, Wolfswinkel EM, Hatef DA, et al. Implant-associated anaplastic large cell lymphoma of the breast: Insight into a poorly understood disease. Can J Plast Surg. 2013;21(2):95-98.
Last Medical Review: 12/05/2014
Last Revised: 10/20/2015